SupportedPT-141: PT-141 increases libido

Peptide Receipt
PT-141 · Checked 2026-07-25
PR-DRAFT-MS09S37U
Claim
PT-141 increases libido
What people report
Anecdotal · Unverified

increased sexual desire · central nervous system action · on-demand usage · nausea side effects

Some people report benefits and others describe concerns or side effects. Experiences vary, and none of this determined the verdict below.

Research
Supported
Confidence · High

Yes. PT-141 (known medically as bremelanotide) is a melanocortin receptor agonist that works via the central nervous system to increase sexual desire. It is FDA-approved for treating acquired, generalized hypoactive sexual desire disorder in premenopausal women.

Evidence
Human
Strong
Animal
None
Lab
None
Registered trials
2
Sources

Research and educational information only. Not medical advice.